1. Home
  2. LIXT vs DGLY Comparison

LIXT vs DGLY Comparison

Compare LIXT & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • DGLY
  • Stock Information
  • Founded
  • LIXT 2005
  • DGLY 2004
  • Country
  • LIXT United States
  • DGLY United States
  • Employees
  • LIXT N/A
  • DGLY N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • LIXT Health Care
  • DGLY Technology
  • Exchange
  • LIXT Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • LIXT 4.2M
  • DGLY 3.8M
  • IPO Year
  • LIXT N/A
  • DGLY N/A
  • Fundamental
  • Price
  • LIXT $1.62
  • DGLY $0.58
  • Analyst Decision
  • LIXT
  • DGLY
  • Analyst Count
  • LIXT 0
  • DGLY 0
  • Target Price
  • LIXT N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • LIXT 1.8M
  • DGLY 101.7K
  • Earning Date
  • LIXT 11-12-2024
  • DGLY 11-29-2024
  • Dividend Yield
  • LIXT N/A
  • DGLY N/A
  • EPS Growth
  • LIXT N/A
  • DGLY N/A
  • EPS
  • LIXT N/A
  • DGLY N/A
  • Revenue
  • LIXT N/A
  • DGLY $23,417,110.00
  • Revenue This Year
  • LIXT N/A
  • DGLY $22.14
  • Revenue Next Year
  • LIXT N/A
  • DGLY N/A
  • P/E Ratio
  • LIXT N/A
  • DGLY N/A
  • Revenue Growth
  • LIXT N/A
  • DGLY N/A
  • 52 Week Low
  • LIXT $1.31
  • DGLY $0.56
  • 52 Week High
  • LIXT $4.42
  • DGLY $3.29
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 43.04
  • DGLY 26.43
  • Support Level
  • LIXT $1.56
  • DGLY $1.01
  • Resistance Level
  • LIXT $1.87
  • DGLY $1.19
  • Average True Range (ATR)
  • LIXT 0.23
  • DGLY 0.10
  • MACD
  • LIXT -0.03
  • DGLY -0.04
  • Stochastic Oscillator
  • LIXT 8.33
  • DGLY 2.35

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: